Director/PDMR Shareholding

Primary Health Properties PLC
21 April 2023
 

Primary Health Properties PLC

("PHP" or the "Company"),

 

 

Director/PDMR shareholding

 

The Company has today been notified that the following information relating to the transaction detailed below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation

 

1

Details of Person Discharging Managerial Responsibility("PCMR")/person closely associated with them ("PCA")

 

(a)

Name

Ivonne Cantu

 

2

Reason for the notification

(a)

Position/status

Non-executive Director

(b)

Initial notification/ amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name of Entity

 

Primary Health Properties PLC

(b)

Legal Entity Identifier

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

 

(a)

Description of the financial instrument

 

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of the transaction

Acquisition under dividend re-investment plan

 

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

£1.053

25,000

 

(d)

Aggregated information

Aggregated volume price

Single transaction

£26,325

 

(e)

Date of transaction

21 April 2023

 

(f)

Place of transaction

London Stock Exchange (xlon)

 

 

 

For further information:

 

 

Primary Health Properties PLC

Toby Newman, Company Secretary & Chief Legal Officer

+44(0) 203 833 3343

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings